Monoclonal Antibody Therapy in Treating Patients With Stage IV Melanoma

Clinical trial NCT00658892 · COMPLETED

Trial details

NCT number: NCT00658892
Sponsor: Mayo Clinic
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Melanoma (Skin)

Start date: 2008-04-08
Primary completion: 2010-02-15
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.